Media Center

Rush Orders in Pharma & Biotech: Three Scenarios, One Rule You Can't Afford to Break

Posted on 2026-07-06 by Jane Smith

No Two Rush Orders Are Alike

In my role coordinating supply for a mid-sized CDMO, I've handled around 200 rush orders over the past 4 years. Some were straightforward—a client needed more DMEM, and we had it in stock. Others were nightmares. Like the time a QC hold-up threatened to delay an entire clinical batch.

Here's the thing: there's no single answer to "how do I handle a rush order?" It depends on what's driving the rush, what's at stake, and how much flexibility you have. This article breaks down the three most common scenarios I've seen, with specific advice for each.

Scenario A: You Need It Yesterday, but the Spec Is Flexible

This is more common than people realize. A researcher runs out of RPMI-1640 on a Friday afternoon and needs it for Monday morning. Or a production line has a last-minute shortfall on a USP-grade chemical. In these cases, the primary constraint is time, not the exact specification.

Concrete example: In March 2024, a client called at 3 PM needing 50 liters of DMEM base media for a Saturday morning start. Normal lead time: 5-7 business days. We offered a comparable medium from a sister facility, rush-shipped overnight. Cost: $380 extra in shipping (base product: $600). Outcome: on time. Alternative: a 48-hour delay, meaning the client would have lost a shift worth roughly $15,000 in production capacity.

What worked here: we had a qualified alternative ready. Most buyers focus on the exact catalog number and completely miss the fact that there are at least 2-3 comparable formulations that will perform identically in their process.

The question everyone asks is "can you meet the spec?" The question they should ask first is "what specifications are truly critical?"

When This Scenario Fails

I don't have hard data on this, but based on our experience, about 20% of these "flexible" rush orders end up causing problems because something subtle was different—a pH buffer, a stabilizer, a different grade of water. Worth checking with your process development team before committing.

Scenario B: The Spec Is Fixed, but You Have Options on the Supply Chain

This scenario is common with GMP-grade materials. The client needs, say, a custom synthesis intermediate with a specific impurity profile. There is no alternative. The only question is how to get it there fastest.

  • Option 1: Pay for premium freight. Air freight from Europe costs 3-5x sea freight but cuts 3 weeks to 3 days.
  • Option 2: Split the order. Air freight a small lot (to keep production running), sea freight the rest.
  • Option 3: What we actually did. Rerouted the shipment through a bonded warehouse closer to the client. Saved 2 days vs. standard air freight, at 60% of the premium freight cost.

The most overlooked factor in these situations is documentation. The chemical itself might arrive in 48 hours, but if the COA or safety data sheet is wrong or missing, it can sit in quarantine for days. I wish I had tracked how many rush orders got delayed by documentation. Anecdotally, I'd say it's about 1 in 5.

So here's what you need to know: when the spec is fixed, time spent on documentation verification is time better spent than time spent on logistics optimization. Sounds backwards? It's not.

Check the paperwork before the shipment leaves. Simple.

Scenario C: Neither Speed Nor Spec Can Be Compromised

This is the worst one. The product is uniquely specified (maybe a custom resin for a purification step), and the deadline is immovable (regulatory submission, clinical trial start). You have no leverage on either dimension.

We had this exact situation in 2023. A client needed a specialty epoxy resin—something that would cross-link at a specific temperature. The normal lead time was 12 weeks. They needed it in 6. The vendor said no.

What we did: we booked the full production slot, paid a 30% premium for priority scheduling, and had a backup plan (a different resin from a different facility, which we pre-qualified in case the primary failed). Total cost: $12,000 extra. But the alternative was missing the clinical milestone, which would've cost the client an estimated $200,000+ in wasted time and regulatory fees.

The lesson: when both dimensions are fixed, you stop optimizing and start buying flexibility. Pay for the expedite. Pay the premium. Bring a backup. You won't be happy about the cost, but you'll be grateful for the result.

Period.

How to Tell Which Scenario You're In

Based on our internal data from 200+ rush jobs, here's a quick diagnostic:

  1. Can you substitute the product with a comparable alternative without requalification? Yes → Scenario A. No → Scenario B or C.
  2. If no substitution, is there any flexibility in the delivery date? Yes → Scenario B. No → Scenario C.
  3. If you're in Scenario C, is the cost of failure higher than the cost of a backup plan? If yes (and it almost always is), invest in redundancy.

That's it. Three scenarios, one principle: know which constraints are real and which are assumed. Most people assume all constraints are fixed. They're usually wrong.

Take it from someone who's learned this the hard way.

Download our 2025 integrated report

For more context on sustainability, quality, and operational governance, request the latest report package from Lonza.